$LTES
Leet Technology Inc

2023 Q2 Form 10-Q Financial Statement

#000168316823008301 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q2
Revenue $95.88K
YoY Change 125.31%
Cost Of Revenue $156.8K
YoY Change -27.32%
Gross Profit -$60.94K
YoY Change -64.82%
Gross Profit Margin -63.56%
Selling, General & Admin $277.6K
YoY Change -36.5%
% of Gross Profit
Research & Development $8.957K
YoY Change -1.22%
% of Gross Profit
Depreciation & Amortization $2.710K
YoY Change -70.73%
% of Gross Profit
Operating Expenses $286.6K
YoY Change -35.79%
Operating Profit -$347.5K
YoY Change -43.9%
Interest Expense $1.386K
YoY Change
% of Operating Profit
Other Income/Expense, Net $36.66K
YoY Change 254.2%
Pretax Income -$310.8K
YoY Change -48.97%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$310.6K
YoY Change -49.01%
Net Earnings / Revenue -323.94%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 152.1M shares
Diluted Shares Outstanding 152.1M shares

Balance Sheet

Concept 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $62.62K
YoY Change 2610.82%
Cash & Equivalents $62.62K
Short-Term Investments
Other Short-Term Assets $12.95K
YoY Change -51.19%
Inventory
Prepaid Expenses
Receivables $28.16K
Other Receivables $0.00
Total Short-Term Assets $103.7K
YoY Change 61.89%
LONG-TERM ASSETS
Property, Plant & Equipment $113.0K
YoY Change -17.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $115.7K
YoY Change -47.49%
TOTAL ASSETS
Total Short-Term Assets $103.7K
Total Long-Term Assets $115.7K
Total Assets $219.5K
YoY Change -22.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $488.0K
YoY Change -21.44%
Accrued Expenses $293.9K
YoY Change 387.57%
Deferred Revenue $285.4K
YoY Change 8.54%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.537M
YoY Change -41.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.537M
Total Long-Term Liabilities $0.00
Total Liabilities $3.537M
YoY Change -41.58%
SHAREHOLDERS EQUITY
Retained Earnings -$11.58M
YoY Change 27.27%
Common Stock $15.11K
YoY Change -1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.783M
YoY Change
Total Liabilities & Shareholders Equity $219.5K
YoY Change -22.86%

Cashflow Statement

Concept 2023 Q2
OPERATING ACTIVITIES
Net Income -$310.6K
YoY Change -49.01%
Depreciation, Depletion And Amortization $2.710K
YoY Change -70.73%
Cash From Operating Activities -$330.9K
YoY Change 82.3%
INVESTING ACTIVITIES
Capital Expenditures -$30.00
YoY Change -99.27%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $30.00
YoY Change -100.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 370.1K
YoY Change 35.56%
NET CHANGE
Cash From Operating Activities -330.9K
Cash From Investing Activities 30.00
Cash From Financing Activities 370.1K
Net Change In Cash 39.26K
YoY Change -11647.06%
FREE CASH FLOW
Cash From Operating Activities -$330.9K
Capital Expenditures -$30.00
Free Cash Flow -$330.8K
YoY Change 86.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001586495
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55053
dei Entity Registrant Name
EntityRegistrantName
LEET TECHNOLOGY INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3590850
dei Entity Address Address Line1
EntityAddressAddressLine1
805, 8th Floor
dei Entity Address Address Line2
EntityAddressAddressLine2
Menara Mutiara Majestic
dei Entity Address Address Line3
EntityAddressAddressLine3
Jalan Othman, Petaling Jaya
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46000
dei Entity Address City Or Town
EntityAddressCityOrTown
Selangor
dei Entity Address Country
EntityAddressCountry
MY
dei City Area Code
CityAreaCode
603
dei Local Phone Number
LocalPhoneNumber
7783 1636
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
151096262 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62622 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36808 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28163 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
156585 usd
CY2023Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
12946 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
11712 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
103731 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
205105 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112995 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
123458 usd
CY2023Q2 LTES Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
2737 usd
CY2022Q4 LTES Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
9046 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
115732 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
132504 usd
CY2023Q2 us-gaap Assets
Assets
219463 usd
CY2022Q4 us-gaap Assets
Assets
337609 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
488030 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
530198 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
293919 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
379872 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
400651 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
413443 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
285355 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
270795 usd
CY2023Q2 LTES Due To Related Party Current
DueToRelatedPartyCurrent
2066181 usd
CY2022Q4 LTES Due To Related Party Current
DueToRelatedPartyCurrent
1157166 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
99624 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2737 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9046 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3536873 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2860144 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3536873 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2860144 usd
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5473581 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5284837 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
652929 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
954793 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
286556 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151096262 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151096262 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152899640 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152899640 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
15110 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
15290 usd
CY2023Q2 LTES Common Stock To Be Cancelled
CommonStockToBeCancelled
-0 usd
CY2022Q4 LTES Common Stock To Be Cancelled
CommonStockToBeCancelled
100 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2773081 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2773001 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12544 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14021 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11584313 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10578195 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8783478 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7803925 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-7513 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-3447 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8790991 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7807372 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
219463 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
337609 usd
CY2023Q2 us-gaap Revenues
Revenues
95876 usd
CY2022Q2 us-gaap Revenues
Revenues
42552 usd
us-gaap Revenues
Revenues
145136 usd
us-gaap Revenues
Revenues
64861 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
156811 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
215749 usd
us-gaap Cost Of Revenue
CostOfRevenue
301896 usd
us-gaap Cost Of Revenue
CostOfRevenue
369945 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-60935 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-173197 usd
us-gaap Gross Profit
GrossProfit
-156760 usd
us-gaap Gross Profit
GrossProfit
-305084 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8957 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9068 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17938 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18065 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
277599 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
437185 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
446253 usd
us-gaap Operating Expenses
OperatingExpenses
670867 usd
us-gaap Operating Expenses
OperatingExpenses
972858 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-347491 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-619450 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-827627 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1277942 usd
CY2023Q2 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2022Q2 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Interest Income Operating
InterestIncomeOperating
77 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1386 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
-0 usd
us-gaap Interest Expense
InterestExpense
5546 usd
us-gaap Interest Expense
InterestExpense
-0 usd
CY2023Q2 LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
503 usd
CY2022Q2 LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
0 usd
LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
-32783 usd
LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
0 usd
CY2023Q2 LTES Foreign Exchange Loss Currency Transaction Gain Loss Before Tax
ForeignExchangeLossCurrencyTransactionGainLossBeforeTax
9321 usd
CY2022Q2 LTES Foreign Exchange Loss Currency Transaction Gain Loss Before Tax
ForeignExchangeLossCurrencyTransactionGainLossBeforeTax
0 usd
LTES Foreign Exchange Loss Currency Transaction Gain Loss Before Tax
ForeignExchangeLossCurrencyTransactionGainLossBeforeTax
15237 usd
LTES Foreign Exchange Loss Currency Transaction Gain Loss Before Tax
ForeignExchangeLossCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q2 LTES Cybersecurity Service Income
CybersecurityServiceIncome
14422 usd
CY2022Q2 LTES Cybersecurity Service Income
CybersecurityServiceIncome
0 usd
LTES Cybersecurity Service Income
CybersecurityServiceIncome
14902 usd
LTES Cybersecurity Service Income
CybersecurityServiceIncome
0 usd
CY2023Q2 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
0 usd
CY2022Q2 us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
10239 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
0 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
10239 usd
CY2023Q2 LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
28340 usd
CY2022Q2 LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
-0 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
28340 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
-0 usd
CY2023Q2 LTES Sundry Income Expense Net
SundryIncomeExpenseNet
42140 usd
CY2022Q2 LTES Sundry Income Expense Net
SundryIncomeExpenseNet
111 usd
LTES Sundry Income Expense Net
SundryIncomeExpenseNet
42505 usd
LTES Sundry Income Expense Net
SundryIncomeExpenseNet
111 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36660 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10350 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5975 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10427 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-310831 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-609100 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-821652 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1267515 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-310831 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-609100 usd
us-gaap Profit Loss
ProfitLoss
-821652 usd
us-gaap Profit Loss
ProfitLoss
-1267515 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-250 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4278 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-310581 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-609100 usd
us-gaap Net Income Loss
NetIncomeLoss
-817374 usd
us-gaap Net Income Loss
NetIncomeLoss
-1267515 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38689 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
233276 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32733 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
266525 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-272142 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-375824 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-788919 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1000990 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152060286 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152060286 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152899640 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152899640 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152060286 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152060286 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152899640 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152899640 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4769184 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
33249 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-658415 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5394350 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
233276 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-609100 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5770174 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7807372 usd
CY2023Q1 us-gaap Dividends
Dividends
94372 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5956 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-510821 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8418521 usd
CY2023Q2 us-gaap Dividends
Dividends
94372 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
32733 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-310831 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8790991 usd
us-gaap Profit Loss
ProfitLoss
-821652 usd
us-gaap Profit Loss
ProfitLoss
-1267515 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5717 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17941 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
63377 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2525 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
LTES Amortization Noncash Financing Cost
AmortizationNoncashFinancingCost
3021 usd
LTES Amortization Noncash Financing Cost
AmortizationNoncashFinancingCost
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
32783 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
28340 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2483 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
-0 usd
us-gaap Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
10239 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-92307 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16984 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1981 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2892 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13028 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
110809 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-95222 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
12493 usd
LTES Accrued Compensation Payable To Officers And Directors
AccruedCompensationPayableToOfficersAndDirectors
10867 usd
LTES Accrued Compensation Payable To Officers And Directors
AccruedCompensationPayableToOfficersAndDirectors
40763 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
31162 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
271273 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2467 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-725161 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-780958 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1998 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9666 usd
LTES Disposal Of Cash From Subsidiaries
DisposalOfCashFromSubsidiaries
-0 usd
LTES Disposal Of Cash From Subsidiaries
DisposalOfCashFromSubsidiaries
11012 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
-0 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
143431 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1998 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-164109 usd
LTES Advances From Repayment To Director
AdvancesFromRepaymentToDirector
-841 usd
LTES Advances From Repayment To Director
AdvancesFromRepaymentToDirector
613 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
940716 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
928734 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
134921 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
806636 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
928121 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-53663 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3933 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25814 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20879 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36808 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23192 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62622 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2313 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62622 usd
CY2023Q2 LTES Working Capital
WorkingCapital
-3433142 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11584313 usd
us-gaap Profit Loss
ProfitLoss
-821652 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zwApTQcSWAbb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><i><span id="xdx_86C_zSPHf66L29q6">Use of estimates and assumptions</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these unaudited condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements during the period reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q2 us-gaap Revenues
Revenues
95876 usd
CY2022Q2 us-gaap Revenues
Revenues
42552 usd
us-gaap Revenues
Revenues
145136 usd
us-gaap Revenues
Revenues
64861 usd
CY2022 us-gaap Income Tax Examination Penalties Expense
IncomeTaxExaminationPenaltiesExpense
20000 usd
us-gaap Payments For Rent
PaymentsForRent
204540 usd
us-gaap Payments For Rent
PaymentsForRent
186415 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
48134 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
78715 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
161640 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
169210 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48645 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
45752 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112995 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
123458 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5717 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
17941 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2737 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9046 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2737 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9046 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2737 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
9046 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
6130 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
2530 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
2737 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
0 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2742 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2737 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Stock Issued During Period Shares Share Based Compensation Gross
StockIssuedDuringPeriodSharesShareBasedCompensationGross
7000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151096262 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151096262 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152899640 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
152899640 shares
us-gaap Net Income Loss
NetIncomeLoss
-817374 usd
us-gaap Net Income Loss
NetIncomeLoss
-1267515 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152060286 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152060286 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152899640 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152899640 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 LTES Due To Related Party Current And Noncurrent
DueToRelatedPartyCurrentAndNoncurrent
2066181 usd
CY2022Q4 LTES Due To Related Party Current And Noncurrent
DueToRelatedPartyCurrentAndNoncurrent
1157166 usd

Files In Submission

Name View Source Status
leet_i10q-063023_htm.xml Edgar Link completed
0001683168-23-008301-index-headers.html Edgar Link pending
0001683168-23-008301-index.html Edgar Link pending
0001683168-23-008301.txt Edgar Link pending
0001683168-23-008301-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
leet_ex3101.htm Edgar Link pending
leet_ex3102.htm Edgar Link pending
leet_ex3201.htm Edgar Link pending
leet_ex3202.htm Edgar Link pending
leet_i10q-063023.htm Edgar Link pending
ltes-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
ltes-20230630_def.xml Edgar Link unprocessable
ltes-20230630_lab.xml Edgar Link unprocessable
ltes-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ltes-20230630_cal.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending